Published in BMC Psychiatry on December 28, 2011
Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries. JAMA Psychiatry (2015) 1.00
The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders. Am J Psychiatry (2016) 0.88
Anxiety and depressive disorders are associated with delusional-like experiences: a replication study based on a National Survey of Mental Health and Wellbeing. BMJ Open (2012) 0.87
Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. Br J Psychiatry (2015) 0.81
Age of Onset and Lifetime Projected Risk of Psychotic Experiences: Cross-National Data From the World Mental Health Survey. Schizophr Bull (2016) 0.77
Cannabis use is a better indicator of poor mental health in women than in men: a cross-sectional study in young adults from the general population. Community Ment Health J (2014) 0.76
Service use for mental health problems in people with delusional-like experiences: a nationwide population based survey. PLoS One (2013) 0.75
Delusional-like experiences are more common in those with cannabis dependence disorder, very early-onset alcohol use or dependence disorders, and daily smokers. Evid Based Ment Health (2012) 0.75
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2008) 5.61
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (1996) 4.52
Variance estimation for complex surveys using replication techniques. Stat Methods Med Res (1996) 3.96
2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry (2009) 3.41
Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med (2010) 3.00
Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction (2004) 2.97
Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol (2002) 2.80
Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res (2000) 2.74
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74
Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol (2005) 2.06
Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry (2011) 2.04
The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol (2005) 2.00
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry (2009) 1.69
Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry (2010) 1.66
Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophr Bull (2009) 1.65
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol (2004) 1.58
Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry (2006) 1.54
Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci (2003) 1.49
The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res (2009) 1.46
Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry (2004) 1.42
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry (2009) 1.40
Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev (2011) 1.31
Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull (1997) 1.21
Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (2010) 1.20
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med (2001) 1.17
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res (2004) 1.09
Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry (2010) 1.07
Demographic correlates of psychotic-like experiences in young Australian adults. Acta Psychiatr Scand (2008) 1.04
The association between general psychological distress and delusional-like experiences: a large population-based study. Schizophr Res (2011) 1.01
Correlates of delusion-like experiences in a non-psychotic community sample. Aust N Z J Psychiatry (2008) 1.00
Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry (2008) 0.99
The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res (2008) 0.99
Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med (2009) 0.94
The association between physical health and delusional-like experiences: a general population study. PLoS One (2011) 0.91
Relevant dimensions of delusions: continuing the continuum versus category debate. Schizophr Res (2007) 0.90
Cannabis use at a young age is associated with psychotic experiences. Psychol Med (2010) 0.89
Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des (2009) 0.87
Cannabis and the increased incidence and persistence of psychosis. BMJ (2011) 0.86
The association between trauma and delusional-like experiences. Psychiatry Res (2011) 0.86
A prospective study of smoking in young women and risk of later psychiatric hospitalization. Nord J Psychiatry (2010) 0.83
Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction (2011) 0.82
Impact of substance use on the onset and course of early psychosis. Schizophr Res (2005) 0.81
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02
Adverse health effects of non-medical cannabis use. Lancet (2009) 6.25
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
Cannabis use and mental health in young people: cohort study. BMJ (2002) 3.26
Health of the world's adolescents: a synthesis of internationally comparable data. Lancet (2012) 3.17
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
Recent increase in detection of alprazolam in Victorian heroin-related deaths. Med J Aust (2013) 2.71
Lifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA (2011) 2.50
The ratio of non-fatal to fatal heroin overdose. Addiction (2003) 2.38
Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction (2010) 2.14
Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry (2011) 2.04
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction (2009) 2.03
Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 2.02
Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ (2013) 1.95
A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction (2003) 1.91
Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood. PLoS Med (2009) 1.89
The increasing mortality burden of liver disease among opioid-dependent people: cohort study. Addiction (2011) 1.87
Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol (2012) 1.80
Relationship between gross domestic product and duration of untreated psychosis in low- and middle-income countries. Br J Psychiatry (2008) 1.66
Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry (2010) 1.66
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain (2015) 1.62
Focal adhesion dynamics are altered in schizophrenia. Biol Psychiatry (2013) 1.61
Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry (2007) 1.59
1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett (2003) 1.59
Advanced paternal and grandpaternal age and schizophrenia: a three-generation perspective. Schizophr Res (2011) 1.57
Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech (2010) 1.57
Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys (2009) 1.55
The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. Am J Psychiatry (2005) 1.54
People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 1.53
Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet (2011) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect (2007) 1.50
Opioid dependence latent structure: two classes with differing severity? Addiction (2010) 1.49
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (2014) 1.49
Cannabis dependence in young adults: an Australian population study. Addiction (2002) 1.47
Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord (2003) 1.47
Exposure to opioid maintenance treatment reduces long-term mortality. Addiction (2008) 1.44
Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Drug Alcohol Rev (2008) 1.44
A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull (2012) 1.43
Age- and education-corrected independent normative data for the RBANS in a community dwelling elderly sample. Clin Neuropsychol (2003) 1.41
UK classification of cannabis: is a change needed and why? Lancet (2007) 1.38
An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data. Addiction (2011) 1.35
Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction (2008) 1.35
Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev (2011) 1.34
What are the policy implications of the evidence on cannabis and psychosis? Can J Psychiatry (2006) 1.31
Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction (2009) 1.29
HIV due to female sex work: regional and global estimates. PLoS One (2013) 1.29
Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behav (2010) 1.27
Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being. Br J Psychiatry (2002) 1.26
The structure of psychopathology: toward an expanded quantitative empirical model. J Abnorm Psychol (2012) 1.25
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev (2010) 1.24
The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. J Child Psychol Psychiatry (2014) 1.24
Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend (2003) 1.24
Sociodemographic predictors of transitions across stages of alcohol use, disorders, and remission in the National Comorbidity Survey Replication. Compr Psychiatry (2008) 1.24
Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend (2009) 1.21
Examining the repeatable battery for the assessment of neuropsychological status: factor analytic studies in an elderly sample. Am J Geriatr Psychiatry (2006) 1.20
Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up. Pediatr Blood Cancer (2008) 1.20
Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (2010) 1.20
Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One (2012) 1.19
A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf (2009) 1.18
Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res (2005) 1.18
Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. J Child Psychol Psychiatry (2013) 1.16
Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol (2005) 1.16
Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab (2011) 1.15
Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison. Drug Alcohol Depend (2005) 1.15
Predicting the impact of the 2011 conflict in Libya on population mental health: PTSD and depression prevalence and mental health service requirements. PLoS One (2012) 1.15
The adverse health effects of chronic cannabis use. Drug Test Anal (2013) 1.14
Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial. PLoS One (2011) 1.14
Posttraumatic stress disorder among female street-based sex workers in the greater Sydney area, Australia. BMC Psychiatry (2006) 1.13
Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res (2006) 1.13
Regression-based formulas for predicting change in RBANS subtests with older adults. Arch Clin Neuropsychol (2005) 1.13
The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol (2011) 1.13
Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav (2010) 1.12
Disorders without borders: current and future directions in the meta-structure of mental disorders. Soc Psychiatry Psychiatr Epidemiol (2015) 1.10
Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res (2005) 1.10
The importance of timing of transitions for risk of regular smoking and nicotine dependence. Ann Behav Med (2008) 1.09
Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry (2011) 1.09
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res (2004) 1.09
A descriptive epidemiology of substance use and substance use disorders in Nigeria during the early 21st century. Drug Alcohol Depend (2007) 1.09
Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study. Addiction (2007) 1.08
Cannabis use and the risk of developing a psychotic disorder. World Psychiatry (2008) 1.08
Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS. Arch Clin Neuropsychol (2003) 1.08